JAKARTA, 16 April 2025 – Fullerton Health Indonesia today officially launched its first Executive Health Screening Centre (EHS) in Jakarta, the fifth such centre in the Fullerton Health Group’s executive health screening portfolio across Asia.
This prestigious award recognises our team's dedication to transforming patient care through forward-thinking innovation and service excellence.
Fullerton Health is proud to announce the launch of its 2023 Sustainability Report. Understanding the urgency of the climate agenda, FHG, in the second year of Sustainability reporting, has incorporated a carbon plan. In addition to highlighting the company’s ongoing efforts to enhance sustainability across its operations in Singapore, the Philippines and beyond, FHG has also put in place policies and metrics to govern and measure our contributions toward a greener world. As a leading healthcare provider in Asia, Fullerton Health remains committed to reducing its environmental footprint while continuing to provide top notch medical services.
Fullerton Health officially opened the Executive Health Screening Centre in the Philippines at Bonifacio Global City on June 30th.
Fullerton Health Corporation Limited (“Fullerton Health” or the “Company”) announced today that it has come into an agreement with Far East Drug (B.V.I.) Co. Ltd. (“Far East Drug” or "FED"), involving an investment in a majority stake in the business by Far East Drug.
The opening ceremony was graced by Mr Kuen Loon Ho, Group CEO of Fullerton Health Group and Mr Alain Durand, MD of Fullerton Health Indonesia. We were also honored to have Dr. Herman Kurniawan Sp.PK, Founder of GS Group and Bapak Ridwan S.IP, Representative from the South Tangerang Health Service.
Fullerton Health Group (FHG) continues to make important strides toward integrating its sustainability goals within its operations and ecosystem. The release of its FY2022 Sustainability Report underscores the Group's commitments and progress in achieving its sustainability goals. The report reflects FHG's strong partnerships and collective action in building a sustainable future.
The modern healthcare organisation is defined by its adaptability to the needs of its stakeholders, particularly patients who are no longer willing to endure long waiting times for medical attention, and a strained workforce that could use a gentle technological assist.
In a post pandemic and inflationary era, corporations are marked by dual pressures of regional market expansion and cost containment, Global Assistance and Healthcare (GAH)
Fullerton Health Corporation Limited (“Fullerton Health” or the “Company”) announced today that it has completed a merger led by RRJ Capital (“RRJ”) involving an equity injection by the private equity firm and a senior loan totalling S$390 million. The merger delivers a stronger balance sheet and a new capital structure which will propel post-pandemic growth opportunities for the pan-Asian healthcare provider.
Fullerton Healthcare CorporationLimited (“Fullerton Health” or the “Company”) is pleased to announce that it has reached a definitive settlement agreement
Fullerton Healthcare Group (Fullerton Healthcare), the leading provider of corporate healthcare solutions...
Programmes & Projects Ending Workplace TB Tuberculosis (TB) is the world’s deadliest infectious disease –killing 1.5 million people in 2018, more than HIV/AIDS and malaria deaths combined. Of the 10 million new cases of TB, only 7 million were diagnosed, meaning that 3 million people with TB each year go unaccounted for. Many of these […]
Programmes & Projects Zero TB We have partnered with local stakeholders, such as Yogyakarta City Government and Yogyakarta Provincial Health Office in a pilot programme called ZeroTB Yogyakarta in 2019, to screen adults and children boarding schools. A total of 900 screenings and 865 X-rays were completed.
Programmes & Projects World TB Day 2020 To commemorate World TB Day and as part of Fullerton Health’s “Ending Workplace TB” initiative launched at the World Economic Forum in Davos in 2020, Fullerton Health Indonesia started a TB-screening program on 9-20 March 2020 for all employees based in Jakarta. This screening aimed to assist government […]
Programmes & Projects Implementor Partner for MoH TB Screening Since 2019, Fullerton Health Indonesia has been the appointed Implementor Partner by Indonesia’s Ministry of Health (MoH) for TB screening, covering a population of 150,000 people across high-risk population groups in factories, boarding schools and prisons. President Joko Widodo launched the Ministry of Health’s event “Gerakan […]
Programmes & Projects Tantang TB Project (Indonesia) The project was developed in support of The Global Fund and the Indonesian government’s goal to eliminate tuberculosis by 2030. In 2018, Fullerton Health Foundation partnered with The Global Fund to successfully pilot the Tantang Tuberculosis Project, with the goal of increasing detection of tuberculosis in Indonesia. Through […]
Programmes & Projects Eradicating TB in Indonesia Indonesia is the second highest burden country in the world for tuberculosis (TB), and TB is the fourth largest cause of death in the country. There are about one million people in Indonesia who are infected with TB every year. With treatment, TB is curable, and that is […]